Anti-S35G2/ SLC35G2/ ™EM22 monoclonal antibody

Anti-S35G2/ SLC35G2/ ™EM22 antibody for FACS & in-vivo assay

Target products collectionGo to SLC35G2/SLC35G2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1609-Ab-1/ GM-Tg-hg-MP1609-Ab-2Anti-Human SLC35G2 monoclonal antibodyHuman
GM-Tg-rg-MP1609-Ab-1/ GM-Tg-rg-MP1609-Ab-2Anti-Rat SLC35G2 monoclonal antibodyRat
GM-Tg-mg-MP1609-Ab-1/ GM-Tg-mg-MP1609-Ab-2Anti-Mouse SLC35G2 monoclonal antibodyMouse
GM-Tg-cynog-MP1609-Ab-1/ GM-Tg-cynog-MP1609-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC35G2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1609-Ab-1/ GM-Tg-felg-MP1609-Ab-2Anti-Feline SLC35G2 monoclonal antibodyFeline
GM-Tg-cang-MP1609-Ab-1/ GM-Tg-cang-MP1609-Ab-2Anti-Canine SLC35G2 monoclonal antibodyCanine
GM-Tg-bovg-MP1609-Ab-1/ GM-Tg-bovg-MP1609-Ab-2Anti-Bovine SLC35G2 monoclonal antibodyBovine
GM-Tg-equg-MP1609-Ab-1/ GM-Tg-equg-MP1609-Ab-2Anti-Equine SLC35G2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1609-Ab-1/ GM-Tg-hg-MP1609-Ab-2; GM-Tg-rg-MP1609-Ab-1/ GM-Tg-rg-MP1609-Ab-2;
GM-Tg-mg-MP1609-Ab-1/ GM-Tg-mg-MP1609-Ab-2; GM-Tg-cynog-MP1609-Ab-1/ GM-Tg-cynog-MP1609-Ab-2;
GM-Tg-felg-MP1609-Ab-1/ GM-Tg-felg-MP1609-Ab-2; GM-Tg-cang-MP1609-Ab-1/ GM-Tg-cang-MP1609-Ab-2;
GM-Tg-bovg-MP1609-Ab-1/ GM-Tg-bovg-MP1609-Ab-2; GM-Tg-equg-MP1609-Ab-1/ GM-Tg-equg-MP1609-Ab-2
Products NameAnti-SLC35G2 monoclonal antibody
Formatmab
Target NameSLC35G2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC35G2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S35G2/ SLC35G2/ ™EM22 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1609
    Target NameSLC35G2
    Gene ID80723,245020,315957,716881,485675,101095366,511543,100053344
    Gene Symbol and SynonymsGm519,SLC35G2,™EM22
    Uniprot AccessionQ8TBE7,Q5M7A3
    Uniprot Entry NameS35G2_HUMAN,S35G2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168917
    Target ClassificationN/A

    The target: SLC35G2, gene name: SLC35G2, also named as ™EM22. Located in Golgi apparatus and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.